glucose, (beta-d)-isomer has been researched along with Hyperphagia in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, X; Cowley, M; Cui, L; Geng, F; Huang, L; Huang, Z; Roelfsema, F; Tan, C; Wang, W; Wu, M | 1 |
| Abiru, N; Ando, T; Haraguchi, A; Hongo, R; Horie, I; Ito, A; Kawakami, A; Nakamura, T; Natsuda, S; Sagara, I | 1 |
| Hamamoto, H; Noda, M | 1 |
| Furuke, S; Kanno, K; Komiya, C; Miyachi, Y; Ogawa, Y; Shiba, K; Shimazu, N; Tsuchiya, K; Yamaguchi, S | 1 |
| Cullen, MJ; Devenny, JJ; Godonis, HE; Harvey, SJ; Pelleymounter, MA; Rooney, S | 1 |
5 other study(ies) available for glucose, (beta-d)-isomer and Hyperphagia
| Article | Year |
|---|---|
Dapagliflozin partially restores reproductive function in MC4R KO obese female mice.
Topics: Animals; Benzhydryl Compounds; Female; Glucosides; Growth Hormone; Human Growth Hormone; Humans; Hyperphagia; Luteinizing Hormone; Mice; Mice, Knockout; Obesity; Receptor, Melanocortin, Type 4 | 2022 |
Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment.
Topics: Adolescent; Adult; Aged; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Energy Intake; Female; Glucosides; Humans; Hyperphagia; Male; Middle Aged; Sodium-Glucose Transport Proteins; Sugars; Surveys and Questionnaires; Young Adult | 2018 |
Body Weight Gain and Hyperphagia After Administration of SGLT-2 Inhibitor: A Case Report.
Topics: Adult; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Humans; Hyperphagia; Male; Sodium-Glucose Transporter 1; Weight Gain | 2015 |
Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.
Topics: Adipose Tissue; Adult; Animals; Body Weight; Diabetes Mellitus, Type 2; Diet, High-Fat; Drug Evaluation, Preclinical; Energy Intake; Epididymis; Glucose; Glucosides; Humans; Hyperphagia; Hypoglycemic Agents; Insulin Resistance; Leptin; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Organ Size; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Weight Loss | 2016 |
Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats.
Topics: 3-Hydroxybutyric Acid; Animals; Anti-Obesity Agents; Benzhydryl Compounds; Blood Glucose; Caloric Restriction; Diet; Dose-Response Relationship, Drug; Drinking; Energy Intake; Glucosides; Hyperphagia; Insulin; Male; Obesity; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Respiration; Sodium-Glucose Transport Proteins; Treatment Outcome; Weight Loss | 2012 |